Skip to content

The Effect of a Passive Hip Exoskeleton on Daily-life Fatigue in Older Adults

Evaluating and Monitoring Physical Fatigue While Performing Functional Activities

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07359573
Enrollment
15
Registered
2026-01-22
Start date
2025-12-11
Completion date
2026-06-01
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, Older Adults (65 Years and Older)

Brief summary

This crossover study investigates whether a passive lower-limb exoskeleton (Exoband) can reduce perceived exertion during everyday mobility tasks in older adults. Participants complete the fatigue protocol- a structured sequence of daily challenging tasks (e.g., overground walking, stair and slope walking, obstacle avoidance)-once with the Exoband and once without it, in randomized order and separated by a one-week washout period. During each session, distance covered until fatigue, rate of perceived exertion, physiological and gait parameters are recorded. The aim is to determine whether exoskeleton assistance enhances mobility performance and reduces functional fatigue across older adults.

Interventions

The participant will be asked to execute a protocol in the movement lab that induces progressive feelings of fatigue. This protocol includes a sequence of relevant functional activities, such as stair walking, slope walking, crouching, walking different path shapes. During this execution the Ratings of Perceived Exertion will be questioned, and simultaneously physiological and movement data will be collected.

DEVICEExoband

The participant will wear the Exoband (Moveo), which is a lightweight, soft wearable exoskeleton designed to assist walking by providing elastic support to the hip during gait. It uses passive elastic elements to store and release energy in sync with the user's movement, reducing muscular effort without motors or batteries. The system is unobtrusive and aims to support mobility while preserving natural movement patterns.

Sponsors

Vrije Universiteit Brussel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \> 65 years old * Healthy physical condition

Exclusion criteria

* Physical injury or disorder that doesn't allow good physical performance

Design outcomes

Primary

MeasureTime frameDescription
Changes in the Ratings of Perceived Exertion throughout the protocol executionThrough study completion, an average of 1-2 weeks.The subjective feelings of fatigue will be evaluated through the Ratings of Perceived Exertion, using the modified Borg Scale (score ranging from 0 'no exertion' to 10 'maximal exertion'). This will be expressed verbally by the participant throughout the execution of the protocol.

Secondary

MeasureTime frameDescription
Changes in muscle activity (surface EMG) throughout the protocol executionThrough study completion, an average of 1-2 weeks.Muscle activity data will be collected continuously throughout the protocol execution. Data acquisition will occur in a synchronized manner.
Changes in heart rate (variability) (ECG sensors) throughout the protocol executionThrough study completion, an average of 1-2 weeks.Cardiorespiratory data (Heart rate) will be collected continuously throughout the protocol execution. Data acquisition will occur in a synchronized manner.
Changes in muscle oxygen saturation (Moxy Monitor) throughout the protocol executionThrough study completion, an average of 1-2 weeks.Oxygen saturation data will be collected continuously throughout the protocol execution. Data acquisition will occur in a synchronized manner.
Changes in electrodermal activity (Galvanic Skin Response - finger electrodes) throughout the protocol executionThrough study completion, an average of 1-2 weeks.Electrodermal activity data will be collected continuously throughout the protocol execution. Data acquisition will occur in a synchronized manner.
Changes in motion data (IMU sensors) throughout the protocol executionThrough study completion, an average of 1-2 weeks.Inertial Measurement Unit (IMU) data will be collected continuously throughout the protocol execution. Data acquisition will occur in a synchronized manner.
Changes in respiratory rate (respiratory chest band) throughout the protocol executionThrough study completion, an average of 1-2 weeks.Respiratory data will be collected continuously throughout the protocol execution. Data acquisition will occur in a synchronized manner.

Countries

Belgium

Contacts

PRINCIPAL_INVESTIGATORDavid Beckwée, PhD

Vrije Universiteit Brussel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026